结直肠癌中的瘤基因CELF6:通过调节HOXA5的mRNA稳定性来准干细胞样性质
Zhiming Fu1, Xiang Wang1, Zhiju Chen1
1Department of General Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, 570311 Haikou, Hainan, China.
Frontiers in bioscience (Landmark edition)
|November 30, 2024
概括
通过降低HOXA5.5的调节,CELF6抑制了结直肠癌 (CRC) 的发育和进展. 恢复CELF6为CRC患者提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症干细胞 (CSCs) 驱动着结直肠癌 (CRC) 的发展和进展.
- 在CRC组织中,CELF6的表达下降.
- 在CRC中CELF6的作用仍然在很大程度上未被探索.
研究的目的:
- 研究CELF6在结直肠癌中的功能和分子机制.
- 为了确定CRC中CELF6的预后意义.
主要方法:
- 使用UALCAN,PrognoScan和TIMER进行CELF6和HOXA5表达和预后的生物信息分析.
- 通过qRT-PCR,免疫血栓和免疫组织化学对CELF6表达的实验验证.
- 在体外和体外功能测试以评估CELF6对CRC细胞增殖,干细胞和瘤发生的影响,以及机械学研究.
主要成果:
- 在CRC中,CELF6的调控下降,并且与预后不佳有关.
- 过度表达CELF6抑制CRC细胞的增殖和干细胞,诱导G1细胞周期停止.
- 通过调节HOXA5的mRNA稳定性,CELF6抑制了CRC的进展,HOXA5倒置逆转了CELF6的抑制作用.
结论:
- CELF6 作为干性抑制剂和CRC进展的调节剂.
- CELF6代表了结直肠癌的潜在新型治疗标.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K


